Related by context. Frequent words. (Click for all words.) 63 Negative Syndrome 63 Scale PANSS 62 A.M. Best Revises Outlook 61 Outlook Remains 60 Outlook Revised 55 Main Outcome Measures 55 PANSS 54 Study Demonstrates 54 estrogen receptor ER 54 Training Effectiveness 54 Accentuate 54 Clinical Trial Results 53 Significantly Improved 53 FY# Guidance 53 Supplier Deliveries 53 NLX P# 52 Guides FY# 52 Montgomery Asberg Depression 52 Revises Outlook 52 Looks Bearish 52 Natural Catastrophe Stress 52 Alzheimer Disease Assessment 52 HBsAg 52 Positive 52 Pharmacodynamic 52 Rating Scale MADRS 51 Currency Majors Technical 51 Economic Optimism 51 Confirmatory 51 Looks Bullish 51 Stronger Than Expected 51 Prognostic 51 Phase III Trial 51 Raises FY# EPS 51 Repeatability 50 Meets Primary Endpoint 50 Drug Shows Promise 50 Recurring Revenue 50 Significantly Improves 50 Cuts FY# EPS 50 HORIZONS AMI trial 50 Stress Testing 50 ADAS cog 50 Meta Analysis 50 0 Thumbs Up 50 ForexTrend 1H Mataf Trend 50 Cholesterol Drugs 50 Backs FY# EPS 49 Prostate Cancer Risk 49 Medication Adherence 49 Guidance Quick Facts 49 Abcourt Barvue project 49 Pharmacokinetic 49 rheumatoid factor 49 sensitivity specificity 49 Cholesterol Levels 49 Improves Survival 49 ADHD Rating Scale 49 pharmacodynamic effects 49 means optimists outnumber 49 Expanded Disability Status 49 Ischemic Stroke 49 Obese Patients 49 Stocks Waver 49 Tops Expectations 48 ABSORB trial 48 Visual Analog Scale 48 Sees Positive 48 Patient Outcomes 48 news sraIndex score 48 SUCCEED trial 48 Visual acuity 48 Fundamental Outlook 48 Primary Endpoint 48 antiviral efficacy 48 Revenues Decline 48 Drug Candidate 48 Inflation Worries 47 Risk Rating 47 Lung Cancer Risk 47 Bankrate Mortgage Rates 47 EQ 5D 47 immunostaining 47 Dollar Rises Against 47 retest reliability 47 RBC Expectations 47 Growth Slowing 47 Retest 47 Global Impression 47 Net Loss Narrows 47 Lowers Outlook 47 Survival Rates 47 Immune Cells 47 teriflunomide 47 Cognitive Function 47 Analyst Upgrade 47 means pessimists outnumber 47 Preliminary Third Quarter 47 Help Predict 47 Preliminary Results 47 clinically meaningful improvement